Ferrex 150 Plus Capsules By Breckenridge Overview & Drug Interactions

Check For Interactions With Ferrex 150 Plus Capsules

Supplement: Ferrex 150 Plus Capsules by Breckenridge

Ferrex 150 Plus Capsules Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Ferrex 150 Plus Capsules by Breckenridge

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 90
UPC/BARCODE 351991703907

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin C
50 mg
Vitamin C 56%
Iron
150 mg
Iron 833%
Succinic Acid
50 mg
Succinic acid --

Other Ingredients:
Gelatin
Crospovidone
Stearic Acid
Croscarmellose Sodium
Citric Acid
Microcrystalline Cellulose
Polyethylene Glycol
Titanium Dioxide
Polyvinylpyrrolidone
FD&C Yellow No. 6 Lake
Silica
FD&C Red No. 40 Lake


Label Statments:


Suggested/Recommended/Usage/Directions
- Indications and Usage: Ferrex 150 Plus may be useful in the dietary management of iron deficiencies. Dosage and Administration: Usual adult dosage is 1 or 2 capsules daily, or as directed by a physician or health-care provider. Do not exceed recommended dosage.
Precautions
- Do not exceed recommended dosage.
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
- If pregnant or breast-feeding, ask a health professional before use.
- Do not use this product if the inner safety seal under the cap is torn, broken or missing.
- Warning: Reproductive harm - www.P65Warnings.ca.gov.
- To report a serious adverse event contact: 1-800-367-3395.
FDA Disclaimer Statement
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
General Statements
- How Supplied: Ferrex 150 Plus is supplied as an orange and white capsule, imprinted “B703”, 51991-703-90.
- All substitutions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.
- Breckenridge A Towa Company
- For information on applicable patents, please visit www.bpirx.com
Storage
- Store at 25 degrees C (77 degrees F); excursions permitted to 15 degrees - 30 degrees C (59 degrees - 86 degrees F). See USP Controlled Room Temperature. Protect from light and moisture. Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP/NF.
FDA Statement of Identity
- Dietary Supplement
Brand IP Statement(s)
- Sumalate (Ferrous Asparto Glycinate) is a registered trademark of Albion International, Inc., Clearfield, Utah and is licensed exclusively to Breckenridge Pharmaceutical, Inc., for certain iron products.
Formula
- Vitamin C is provided as a blend of Calcium Ascorbate and Calcium Threonate

Brand Information

See all products by this brand

Manufactured by
Name Contract Pharmacal Corp.
City Hauppauge
State NY
ZipCode 11788
Distributed by
Name Breckenridge Pharmaceutical, Inc.
City Berlin
State CT
ZipCode 06037

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.